Fig. 2From: A long-range interactive DNA methylation marker panel for the promoters of HOXA9 and HOXA10 predicts survival in breast cancer patientsEstimation of CpGs on HOXA9 and HOXA10 promoters as diagnostic and prognostic markers for breast cancer. a Differences in the methylation status of the CpGs between tumor and paired normal tissues (diagnostic value). b Association between survival and the CpG methylation status (prognostic value, black: high, gray: low). c Correlation between methylation level of the CpGs and expression level of the HOXA9, HOXA10, and HOXA11 genesBack to article page